FdaApplication

ANDA 216067

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2022-03-29

Products (3)

ProductActive ingredientStrengthDosage form
NIFEDIPINENIFEDIPINE30MGTABLET, EXTENDED RELEASE;ORAL
NIFEDIPINENIFEDIPINE90MGTABLET, EXTENDED RELEASE;ORAL
NIFEDIPINENIFEDIPINE60MGTABLET, EXTENDED RELEASE;ORAL

3 products